Search

Issue
Title
Authors
Primary resistance to anti-HER2 therapy: mechanisms of development and ways to overcome
Dashyan G.A., Dzhelialov E.S., Konstantinova V.V., Gronskaya Y.A., Murskikh A.D., Akhmedov R.M., Tyusenko A.E., Olchonova A.A., Dyakonenko Z.V., Sereda O.A., Belousov A.M.
Adjuvant and neoadjuvant therapy for (based on the materials of the 16th St. Gallen International Breast Cancer Conference)
Semiglazov V.F., Semiglazov V.V.
De-escalation and escalation of treatment of patients with HER2-positive breast cancer
Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., Komyakhov A.V., Semiglazova T.Y., Paltoev R.M., Donskikh R.V., Tseluyko A.I., Artemyeva A.S., Bashlyk V.O., Miryusupova G.F., Dashyan G.A.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.A.
Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
Zhukova L.G., Artamonova E.V., Ganshina I.P., Kolyadina I.V., Vorontsova K.A., Sekhina O.V., Grechukhina K.S.
Kadsila (trastuzumab emtanzin, T-DM1): pervyy kon\"yugat antitela i khimiopreparata v lechenii HER2-polozhitel'nogo raka molochnoy zhelezy
Borisova E.I., Gutorov S.L., Lichinitser M.R.
Opyt primeneniya trastuzumaba v respublike Bashkortostan
Sakaeva D.D., Kunafina R.I., Popova E.V.
Pertuzumab - novyy vzglyad na HER2-polozhitel'nyy metastaticheskiy rak molochnoy zhelezy
Gan'shina I.P., Zhukova L.G., Tyurin I.E.
TARGETED THERAPY AFTER PROGRESSION OF HER-2-POSITIVE BREAST CANCER
Tat'yana Y.S., Semiglazov V.V., Larisa V.F., Chubenko V.A., Nikita V.B., Fedor V.M., Latipova D.K., Mikhail L.G., Semiglazova T.Y., Semiglazov V.V., Filatova L.V., Chubenko V.A., Brejnev N.V., Moiseenko F.V., Latipova D., Gershanovich M.L.
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
Vladimirova L.Y., Popova I.L., Abramova N.A., Storozhakova A.E., Tikhanovskaya N.M., Novoselova K.A., Lyanova A.A., Ryadinskaya L.A., Yezhova M.O., Teplyakov M.A.
LAPATINIB PRI RAKE MOLOChNOY ZhELEZY
Fray I.V., Perevodchikova N.I.
TARGET THERAPY HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES: NEW PROSPECTS FOR TREATMENT
Yu Semiglazova T., Filatova L.V., Kh Latipova D., Gershanovich M.L., Semiglazova T.Y., Filatova L.V., Khamidovna L.D., Gershanovich M.L.
Example of the integrated approach to treatment of the patient with disseminated stomach cancer taking into account of modern clinical trends
Besova N.S., Trusilova E.V., Obarevich E.S., Tupitsyn N.N., Gorbunova V.A., Davydov M.M., Drobot N.T., Perfiliev B.A., Malikhova O.A.
DVOYNAYa BLOKADA HER2-PETsEPTOPA - NOVOE NAPRAVLENIE V LEChENII RAKA MOLOChNOY ZhELEZY S GIPEREKSPRESSIEY HER2
Gan'shina I.P., Lubennikova E.V., Zhukova L.G.
LEChENIE OPERABEL'NYKh I OTNOSITEL'NO OPERABEL'NYKh FORM RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Dashyan G.A., Semiglazov V.V., Donskikh R.V., Paltuev R.M.
Bevatsizumab (Avastin) v lechenii bol'nykh rakom molochnoy zhelezy
Lud A.N., Gan'shina I.P.
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Zhukova L.G., Ganshina I.P., Zaitsev V.G., Stepanchenko M.V.
ChETYRE ASPEKTA AD\"YuVANTNOY TARGETNOY TERAPII HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Semiglazov V.V.
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Semiglazov V.F., Semiglazov V.V., Dashyan G.A., Krivorotko P.V., Nikolaev K.S., Semiglazova T.Y., Komyakhov A.V., Bessonov A.A., Donskikh R.V., Paltuev R.M., Zernov K.Y.
Herceptin in the treatment of disseminated HER2-positive gastric cancer. Clinical case of successful treatment of elderly patient
Besova N.S., Khokhlova S.V., Gorbunova V.A.
Klinicheskiy sluchay uspeshnogo lecheniya HER-pozitivnogo disseminirovannogo raka zheludka s polnym i prodolzhitel'nym effektom
Vakhabova Y.V., Filimonyuk A.V., Lodygina K.S., Vorontsova K.A., Lichinitser M.R.
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
Zhukova L.G., Lichinitser M.R.
1 - 22 of 22 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies